Target and Its Patented Drug(s)

Content Navigation (  All   None )                                      
Target General Information
Patent(s) and the Corresponding Patented Drug(s)
References
Target General Information  Top
Target ID T21507 Target Info
Target Name Fatty acid-binding protein 5 (FABP5)
Synonyms Psoriasis-associated fatty acid-binding protein homolog; PA-FABP; Fatty acid-binding protein, epidermal; Fatty Acid BindingProtein mal1; Epidermal-type fatty acid-binding protein; E-FABP
Target Type Patented-recorded Target
Gene Name FABP5
Biochemical Class Fatty acid binding protein
UniProt ID
FABP5_HUMAN
Patent(s) and the Corresponding Patented Drug(s)  Top
World Intellectual Property Organization (WIPO)
Patent ID WO2014146995
Title Urea Derivatives and Their Use As Fatty-Acid Binding Protein (Fabp) Inhibitors.
Abstract The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, W, A and B are as described herein, compositions including the compounds and methods of using the compounds.
Applicant(s) F. Hoffmann-La Roche Ag
Representative Drug(s) D01TJW Drug Info IC50 = 3790 nM Click to Show More [1]
United States Patent and Trademark Office (USPTO)
Patent ID US2014029723
Title Compositions, formulations and Methods for Treating Ocular Diseases.
Representative Drug(s) D0CT9O Drug Info IC50 = 20 nM Click to Show More [1]
Patent ID US20130116234
Title Aryl-Quinoline Derivatives.
Representative Drug(s) D06JEA Drug Info IC50 = 51.2 nM Click to Show More [1]
References  Top
REF 1 Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.